SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 119 filers reported holding SUTRO BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,492,100 | -19.8% | 430,000 | +7.5% | 0.01% | -38.5% |
| Q2 2023 | $1,860,000 | +57.9% | 400,000 | +56.9% | 0.01% | +18.2% |
| Q1 2023 | $1,178,100 | -64.9% | 255,000 | -38.6% | 0.01% | -81.4% |
| Q4 2022 | $3,353,200 | +67.8% | 415,000 | +15.3% | 0.06% | +168.2% |
| Q3 2022 | $1,998,000 | +0.9% | 360,000 | -5.3% | 0.02% | -4.3% |
| Q2 2022 | $1,980,000 | -3.6% | 380,000 | +52.0% | 0.02% | -8.0% |
| Q1 2022 | $2,055,000 | -39.9% | 250,000 | +8.7% | 0.02% | -32.4% |
| Q4 2021 | $3,422,000 | -13.7% | 230,000 | +9.5% | 0.04% | -7.5% |
| Q3 2021 | $3,967,000 | +1.6% | 210,000 | 0.0% | 0.04% | +25.0% |
| Q2 2021 | $3,904,000 | -7.0% | 210,000 | +13.8% | 0.03% | -20.0% |
| Q1 2021 | $4,199,000 | -32.0% | 184,501 | -35.1% | 0.04% | -46.7% |
| Q4 2020 | $6,177,000 | +63.9% | 284,501 | -24.1% | 0.08% | +53.1% |
| Q3 2020 | $3,769,000 | +27.1% | 375,000 | -1.8% | 0.05% | -7.5% |
| Q2 2020 | $2,965,000 | +290.6% | 382,026 | +413.6% | 0.05% | +307.7% |
| Q1 2020 | $759,000 | -13.7% | 74,385 | -6.9% | 0.01% | -7.1% |
| Q4 2019 | $879,000 | +8.5% | 79,892 | -10.3% | 0.01% | +7.7% |
| Q3 2019 | $810,000 | -28.8% | 89,081 | -10.9% | 0.01% | +8.3% |
| Q2 2019 | $1,138,000 | -21.4% | 100,000 | -21.3% | 0.01% | -33.3% |
| Q1 2019 | $1,447,000 | +57.6% | 127,005 | +24.7% | 0.02% | +125.0% |
| Q4 2018 | $918,000 | -12.6% | 101,808 | +45.4% | 0.01% | -11.1% |
| Q3 2018 | $1,050,000 | – | 70,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |